Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

- (2013) Volume 5, Issue 3

Spherical Agglomeration Techniques and their Evaluation Parameters

Soni Varinder 1* Rathore M S2
  1. Shri Venkateshwara University,Gajraula (UP)
  2. C T Institute of Pharmaceutical Sciences Jalandhar.
Corresponding Author: Soni Varinder E-mail: balsonpharma@gmail.com
Date of Submission: 06-05-2013 Date of Acceptance: 21-05-2013 Conflict of Interest: NIL Source of Support: NONE
Copyright: © 2013 Soni Varinder et al, publisher and licensee IYPF. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
Related article at Pubmed, Scholar Google
Visit for more related articles at International Journal of Drug Development and Research

Abstract

Spherical agglomeration technique is a specialized and modern method which has been successfully employed to improve flowability, packability, Compressibility, wettability, solubility, and bioavailability of various poorly soluble and poorly Compressible drugs. The different Techniques discussed are Crystallization method, Solvent crystallization method, Quasi- emulsion diffusion method, Ammonia Diffusion method, neutralization method, and solvent agglomeration technique. This article gives a detailed and comprehensive review about different techniques, its advantages, mechanism and application of Spherical agglomeration Technique along with its Evaluation and Characterization methods. The spherical crystals can be Evaluated using FTIR (Fourier Transformation Infra red technique) DSC (Differential Scanning Calorimetry) X-ray Diffraction and Chromatographical methods. This technique also finds its application in improving taste of bitter drugs and in the preparation of nanospheres, microspheres and nano-particles.

Keywords:

Spherical Crystallization, Techniques of Crystallization, Mechanism, Evaluation, Characterization.

INTRODUCTION:

Spherical Crystallization technique is a Particle design technique in which crystallization and agglomeration is carried out simultaneously in one step. This technique has been successfully utilized for improvement of flowability and Compressibility of crystalline drugs. This can be used to prepare crystals of poorly water soluble drugs to increase their solubility and dissolution rate. Therefore, improvement of bioavailability of drugs [1, 2]. Tablets are most stable readily portable and consumed dosage form. Tablets containing sparingly soluble water soluble drugs, the start of dissolution is often delayed by poor wettability of the tablet surface and slow penetration into tablet matrix. This increases dissolution time and release of drug this can be overcome by addition of suitable disintegrant. Spherical Crystallization Technique transforms crystals directly to compact form during crystallization process. It also enables co-precipitation of drugs and encapsulating polymer in the form of spherical particles. Development of novel methods to improve the bioavailability of poorly soluble drugs is a big challenge to formulate solid dosage form. Mechanical Micronization of drugs and use of surfactants during crystallization process are the techniques which are commonly used to improve the Flowability and Compressibility of drugs, by this technique the physio-chemical properties of crystalline drugs can be dramatically improved. This technique can further be used to improve the taste of bitter drugs and to prepare microspheres, nanospheres and nano-particles [3, 4, 5].
Methods of Spherical Crystallization:
1. Conventional Crystallization Process
2. Solvent Change Method
3. Quasi-Emulsion Diffusion Method
4. Ammonia Diffusion Method
5. Neutralization Method
6. Crystal Co-agglomeration Technique
Conventional Crystallization Technique: - (CCT)
Spherical agglomerates are prepared by controlling the physical and chemical properties and can be called as non- conventional crystallization processes [6].
These include:
• Salting out
• Cooling crystallization
• Crystallization using melting
Solvent Change Method [7] : - (SC)
This Technique involves simultaneous crystallization and agglomeration of two or more drugs from good solvent and bridging liquid by addition of non- solvent. To obtain fine crystals the solution of the drug and a good solvent is poured into a poor solvent under controlled condition of temperature and speed. The drawback of this technique is it provides fewer yields, due to co-solvency effect of crystallization solvent. Here lesser amount of bridging liquid will produce fine particle where as larger amount of bridging liquid will produce coarse particles.
Different Steps involved in Solvent Change Method
Quasi-Emulsion Diffusion method [8]: - (QESD)
In this technique good solvent diffuses gradually out of Emulsion droplets into surrounding poor solvent area, and poor solvent diffuses into droplets by which the drug crystallizes inside the droplets. Here the affinity between drug and poor solvent is greater than drug and poor solvent. The crystallization of the drug occurs by counter diffusion of good solvent and poor solvent.
Different Steps involved in Quasi-Emulsion Diffusion method:-
Ammonia diffusion method [9]: - (AD)
Here in this technique the mixture of acetone, ammonia-water and dichloromethane is generally used for crystallization. Here Ammonia-Water acts as bridging liquid and good solvent. Different Steps involved in Ammonia diffusion
Neutralization method [10] :-( NM)
Here in this Technique drug is dissolved in good solvent and placed in cylindrical vessel with constant stirring, during stirring aqueous polymeric solution and one neutral solution are added to neutralize good solvent, which crystallizes out the drug.
Different Steps involved in Neutralization method:- Good solvent + drug added to neutralizing solution
Crystalo- Co-agglomeration Technique [11]: - (CCA)
This Technique is a modification of spherical crystallization technique in which excipients or other drug is used to make spherical crystals and agglomerates. The agglomeration is done using a bridging liquid.
Different Steps involved in Crystal coagglomeration Techniques
This Technique is a modification of spherical crystallization technique in which excipients or
The Steps involved in Spherical Crystallization Process are [12]:-
Flocculation Zone:-Here loose open flocs of particles are formed. In this zone bridging liquid displaces the liquid from the surface of the crystal and crystals are brought in close proximity by agitation.
Zero- growth Zone: - Loose flocs get converted into highly packed pellets in which liquid entrapped is squeezed out followed by squeezing out bridging liquid onto the surface of the small flocs.
Fast growth Zone:-The formation of large size article following random collision of well formed nucleus is called coalescence. Successful collision occurs if surface has slightly excess moisture.
Constant growth Zone: - Here size of the agglomerate formed ceases . The rate determining step in agglomerates growth occurs in zero growth zones. The strength of agglomerates is determined by interfacial tension between bridging liquid and continuous phase, contact angle and ratio of volume of bridging liquid and solid particles.
Factors controlling the Process of Agglomeration [5]:-
Temperature of the System:-
Temperature has significant role to play and has great influence on final shape, size and texture of agglomerates. This may be due to the fact that temperature affects the solubility of drug in ternary system.
Solubility profile:- The proportion of solvent used is determined by carrying out solubility studies and constructing triangular phase diagram to define region of mutual immiscibility by using ternary diagram.
Mode and Intensity of Agitation:-
The Extent of Mechanical agitation in conjugation with amount of bridging liquid determines the rate of formation of agglomerates and its final size. Generally high speed agitation is necessary to disperse bridging liquid throughout the system.
Residence Time:-
The time for which agglomerates remain in reaction mixture is residence time and it affects the strength of agglomerates.
Evaluation parameters for spherical agglomerates:-
Flow Property [13]:-
Flow property of the material depends on the force developed between the particle, particle size, particle size distribution, particle shape, surface texture or roughness and surface area. Flowability of the agglomerates is much improved as the agglomerate exhibits lower angle of repose then that of single crystals. Following are the methods used for determination of flow property
Angle of repose [14]:-
Angle of repose is the common method used for determination of flow property. The angle of repose can be obtained from the equation: Tan G = 2h/d Where h-height of the cone, ddiameter of cone.
Compressibility or Carr’s index [14]:-
A simple indication of ease with which a material can be induced to flow is given by application of compressibility index. I = (1-V/Vo) 100,
Where V = the volume occupied by a sample of the powder after being subjected to a standardized tapping procedure and Vo = the volume before tapping. Value below 15% indicates good flow characteristics and value above 25% indicate poor flowability.
Hausner ratio [14]:-
It is calculated from bulk density and tap density as follows Hausner ratio = Tapped density / Bulk density, Values less than 1.25 indicate good flow (20% Carr index.) and the value greater than 1.25 indicates poor flow (33% Carr index.). If it is between 1.25-1.5 added glident normally to improve flows.
Packability[15,16]:-
Improve packability has been reported for agglomerates prepared by spherical crystallization. The angle of friction, shear cohesive stress and shear indexes are lower than that of single crystals, which can improve the packability of the agglomerates. Kawashima, Y., et al. prepared spherical agglomerates of two solvent systems and compared with those of original powder of the drug. It was found that the packability of agglomerates was improved compared with those of the original crystals and that the agglomerated crystals were adaptable to direct tabletting.
Compression Behaviour Analysis:-
Good Compactibility behavior and Compressibility are essential properties of directly Compressible agglomerates. The Compaction behavior of Crystals is obtained by plotting the relative volume against the Compression Pressure.
Spherical agglomerates possess superior strength in comparison to conventional crystals.
Tablet Elastic Recovery Test [17]:-
In this test put specific quantity of spherical agglomerated crystals sample in a die specific diameter the surface of which was coated with magnesium stearate in advance, then used the universal tensile compression tester to compress the samples at a constant speed. Then measure the thickness of each tablet under maximum pressure and at about 24 h after tablet ejection. The following equation can be used to calculate the elastic recovery ratio (ER).
ER= [(He-Hc)/Hc] x100
About 24 h after the tablet is ejected, its weight, diameter, and thickness can be measured, and its apparent density (Ma) calculated. The following equation can be used to calculate internal tablet porosity (N) from true density (Mt), which can be measured with an air comparison pycnomete
N=1-Ma/Mt
The prepared tablets from agglomerated crystals can be kept in desiccators (silica gel) for about 24 h, and then a hardness tester can be used to measure a load across the diameter of each tablet at a specific compression speed to find the hardness F when crushing. The following equation can be used to calculate the tensile strength T. T=2F/OdL Where: d and
Study of Plasticity and Compressibility:-
For this study use single, flat punches 10mm in diameter, furnished with strain gauge and a displacement transducer compression tools. The strain gauge allows the pressure forces on the upper and lower punches to be followed with force-measuring equipment. The equipment transducer can be fitted over the upper punch. The tablets can be pressed from the control and denoted samples with 0.5% magnesium stearate as a lubricant. A total of 100 tablets could be pressed electrically in continuous operation. During tablet pressing, the data is collected by computer. The energy parameters of 10 tablets can be fixed for the calculation of plasticity and compressibility values. The measurements are repeated three times during the pressing. Plasticity (Pls-m) was determined by Stamm- Mathis
Plasticity (Pls-m) = E2/E2+E3X100 (%)
Where, E2=effective work which includes the useful works invested in deformation and the friction during processing, E3=is the degree of elastic recovery during processing.
E2 AND E3 could be calculated from the force displacement curve. If the plasticity value is near 100, the material has plastic property.
Compressibility [Pr (mass)] was calculated via the following equation.
Compressibility [Pr (mass)] = sx/Wspec = sx/(E2/m) X (Pa /JKg -1 )
Where sx = Tensile strength, Wspec = expresses effective work (E2) invested into the compression of the unit mass of substance (m) at a given compress force.
Mechanical strength:-
Spherical crystals should posse’s good mechanical strength as that directly reflects the mechanical strength of compact or tablet. It can be determine by using the Crushing strength, Friability test.
Wettability:-
The wettability depends on the crystalline and elementary crystal size of the agglomerated crystals. The Crystals with low Crystallinity are more wettable then crystals with higher crystallinity. Following methods can be used to determined wettability of spherical crystals.
Determination of density: Density of saturated solution of drug and spherical crystals in water can be determined using a relative density bottle.
Determination of surface tension: Surface tension of saturated solution of drug and spherical crystals in water can be determined employing stalagmometer.
Determination of porosity: Thickness and diameter of prepared tablet of drug spherical crystals can be determined using vernier calliper and porosity was calculated from apparent density of the tablet
Solubility [18]:-
Solubility can be determined quantitatively using distilled water and other solvent (acid or base) at room temperature (250c).
Dissolution Rate [19]:-
It has been elucidated that the dissolution of agglomerates increases as apparent specific surface area increases. Tabletting compacts partially breaks the agglomerated crystals and thus the average particle size is reduced. If agglomerated crystals shows change in wettability or crystalline form then dissolution study is must. If spherical crystallization is carried out in presence of surfactant then improvement in dissolution rate is must. But compression also increases the particle density, which may adversely affect dissolution. Specific surface area of crystals is found to depend on the method used for spherical crystallization. Therefore it necessary to evaluate the intrinsic dissolution rate of agglomerated crystal sand raw crystals.
Moisture Uptake Study:-
The study indicates the behaviour of uptake of moisture by drug and the prepared spherical crystals, which affect the stability.
Equipments for the Characterization of Spherical Agglomerates:-
1) For Particle shape/surface topography Optical microscopy and Electron scanning microscopy are used.
2) X-ray powder diffraction: X-ray powder diffraction is an important technique for establishing batch-to-batch reproducibility of a crystalline form. The form of crystals in agglomerates was determined by using this technique. An amorphous form does not produce a pattern. Each diffraction pattern is characteristics of a specific crystalline lattice for a given compound.
3) Fourier Transform Infrared spectrometer (FTIR): It is much more useful for distinguishing between solvates and anhydrous form then for identifying polymorphs because of the addition of new stretching frequencies resulting from the salvation.
4) Differential scanning calorimeter (DSC): DSC measures the heat loss or gain resulting from physical or chemical changes within a sample. If a mixture of drugs and polymer is agglomerated together then change in properties of agglomerates can be studied with DSC.

Conclusion:-

The Spherical agglomeration is a specialized particle design technique which could shorten and improve the tablet manufacturing process and thus could reduce cost. Agglomerates thus produced shows excellent improvement in physiochemical properties. The main concern is that the residual organic matter used should be properly checked and monitored as per the regulatory requirements. This is certainly technique of the future.
• If different Techniques could be Compared and Evaluated for Single drug using different additives and the technique showing best results is selected on the basis of improvement in physio-chemical and micrometric properties of poorly water soluble drugs with low bio-availability. This will certainly help in choosing best Technique and additive for the particular drug.

Tables at a glance

Table icon
Table 1
6849

References

  1. Gupta VR, Srinivas M, Patel MM, Jani GK. Spherical crystals of Celecoxib to improve the solubility, dissolution rate and micromeritic properties. Acta Pharm. 2007; 57: 173-184.
  2. Di martino P, Di Cristofaro R, Barthelemy C, Joiris E, Palmeieri FG, Sante M. Improved Compression properties of Propyphenazone spherical Crystals. Int. J. Pharm. 197 (1-2) 95-106 (2000).
  3. Gohle MC, Parikh RK, Shen H, Rubey RR. Improvement in flowability and compressibility of AmpicillineTrihydrate by spherical crystallization. Ind J Pharm Sci. 2003; 634-37.
  4. Ueda M, Nakamura Y, Makita H, Imasato Y, Kawashima Y. Particle design of Enoxacin by spherical crystallization technique II, Characteristics of agglomerated crystals. Chem Pharm Bull. 1991; 39(5):1277-1281.
  5. Patil SV, Sahoo SK. Pharmaceutical overview of spherical crystallization. Der Pharmacia Lettre 2010; 2 (1) 421-426.
  6. Goyal N, Sharma N, Sharma P K, Spherical crystallization: A method of improving powder and tablet characteristics. Der Pharmacia letter, 2010, 2(4):246-25.
  7. Mudit dixit, P.K. kulkarni, P. Subhash Chandra Bose, Rama Reddy. Spherical agglomeration of Indomethacin by Solvent Change method. IJPRD. 2010, 2(9), 33-43.
  8. PrathipatiSrinivasrao, Ganaesan V. Spherical crystallization: a method to improve physiochemical properties. IJPSRR. 6(1), 2011, 60- 63.
  9. Sano A, Kuriki T, Kawashima Y, Takamachi H, Hina T, Niwa T. Particle Design of TolbutamidebySpherical Agglomeration Technique 111 micrometric properties and Dissolution rate of TolbutamideSpoherical agglomerates produced by qesd technique. Chem. {Pharm. Bu. 38: 733-739 (1990).
  10. Kulkarni PK, Nagavi BG, Spherical crystallization, IJPharm. Edu.2002 36(2), 66-71.
  11. Mahadik KR, Pawar AP, Paradkar AR, Kadam S, crystallo-co-agglomeration, A novel technique to obtain Ibuprofen- paracetamol agglomerates. AAPS Pharm Sci Tech. 2004; 5(3): 1-8.
  12. Gupta M M, Srivastava B, Sharma M, Arya V, Spherical crystallization: a tool of particle engineering for making drug powder suitable for direct compression. IJPRD 2010; 12:1-10.
  13. Deshpande MC, Mahadik KR, Pawar AP, Paradkar AR. Evaluation of spherical crystallization as particle size enlargement technique for Aspirin. Ind J Pharm Sci. 1997; 59 (1): 32-34.
  14. Keith Marshall in: Leon Lackman, Herbert A Liberman, Joseph L Kanig. The Theory and Practice of Industrial Pharmacy. 4 th ed. Verghase Publishing House; Bombay: 1991. p. 67- 71, 316-317.
  15. Peleg M., Moreyra R. Effect of Moisture on the Stress Relaxation Pattern of Compacted Powders. PowderTechnol. 1979; 23: 277.
  16. Danjyo K, Hiramatsu A, Otsuka A. Effect of Punch Velocity on the Compressibility and Stress Relaxation of Particles and Granules. J. Soc. Powder Technol. Japan. 1998; 35: 662-670.
  17. Fell JT, Newton JM. Determination of Tablet Strength by the Diametral-compression Test. J. Pharm. Sci. 1970; 5: 688-691.
  18. Jung JY, Yoo SD, Lee SH, Kim KH, Yoon DS, Lee KH. Enhanced solubility and dissolution rate of Itraconazole by a solid dispersion technique. Int J Pharm. 1999; 187: 209-218.
  19. Chourasia MK, Jain SK, Jain S, Jain, NK. Preparation and characterization of agglomerates of Flurbiprofen by spherical crystallization technique. Ind J Pharm Sci. May- June 2003: 287-291.
  20. Amit R, Tapas, Pravin S, Kawashima, Dinesh M, Sakarkar, Spherically agglomerated solid dispersions of Valsartan to Improve Solubility, Dissolution rate and micromeritic properties. IJDD. 2010; 2: 304-313.
  21. Atkinson RM, Belford C, Tomich EG. Effect of particle size on blood Griseofulvin levels in man. Nature 1962; 193: 588-589.
  22. Bausch A, Leuenberger H. Wet spherical agglomeration of proteins as a new method to prepare parenteral fast soluble dosage forms. Int J Pharm. 1994; 101: 63-70.
  23. Bermer GG, Zuiderweg FG. Proceedings of international symposium of fine particles. AIME. 1992; 1524-46.
  24. Bhadra S, Kumar M, jain S, Agrawal S, Agrawal GP. Spherical crystallization of mefenamic acid. Pharm Tech. Feb. 2004. 66-76.
  25. Blandin AF, Mangin D, Rivoire A, Klein JP, Bossoutrot JM. Agglomeration in suspension of salicylic acid fine particles: influence of some process parameters on kinetics and agglomerate final size. Powder Technol. 2003; 130: 316-323.
  26. Bos AS, Zuiderweg FJ. Size of agglomerates in batch wise suspension agglomeration. ChemEng Res Des. 1987; 65a: 187.
  27. Goczo H, Szabo RP, HasznosNezdei M. Development of spherical crystals of acetyl salicylic acid for direct tablet making. Chem Pharm Bull. 2000; 48(12): 1877-81.
  28. Gordon MS, Chowhan ZT. Manipulation of Naproxen particle morphology via the spherical crystallization technique.
  29. Hector GP, Jorge B, Carlo A. Preparation of Norfloxacin spherical agglomerates using the ammonia diffusion system. J Pharm Sci. 1998; 87(4): 519-23.
  30. J bilou M, Ettabia A, Guyot-Hermann, AM, Guyot JS. Ibuprofen agglomeration prepared by phaseseparation. Drug DevInd Pharm. 1990; 25(3): 297-305.
  31. Jarosz PJ, Parrott EL. Compression of granule strength and tablet tensile strength. J Pharm. Sci. 1983; 72(5): 530-34.
  32. Kaur H, Mariappan TT, Singh S. Behavior of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and presence of light Part-III, Various drug substances and excipients. Pharmaceutical Technology. Dec 2003: 52-56.
  33. Kawashima Y, Cui F, Takeuchi H, Hino T, Niwa T, Kiuchi K. Parameters determining the agglomeration behavior and the micrometric properties of spherically agglomerated crystals prepared by spherical crystallization technique with miscible solvent system. Int J Pharm. 1995; 119: 139-147.
  34. Kawashima Y, Niwa T, Handa T, Takeuchi H, Iwamoto T, Itch. Preparation of controlled release microspheres of Ibuprofen with acrylic polymers by a novel quasi emulsion solvent diffusion method. J Pharm Sci.1989; 78(1); 68-72.
  35. Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y, Furuyama S. Characterization of polymorphs of Tranilast anhydrate and Tranilast monohydrate when crystallization by two solvents changes spherical crystallization technique. J Pharm Sci. 1991; 80(5): 472-78.
  36. Kawashima Y, Okumura M, Takenaka H. Spherical crystallization: direct spherical agglomeration of Salicylic acid crystals during crystallization. Science 1982; 216(4): 1127-28.
  37. Kawashima Y., Imai M., Takeuchi H., Yamamoto H., Kamiya K., Hino T. Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tableting designed by spherical crystallization process. Powder Technol. 2003; 130: 283-289.
  38. Kawashima YF, Takeuchi CH, Niwa T, Hino T, Kiuchi K. Improved Static Compression Behaviors and Tablet abilities of Spherically Agglomerated Crystals Produced by the Spherical Crystallization Technique with a Two-solvent System. Pharm. Res.1995; 12 (7): 1040-1044.
  39. Kulkarni P. K., Dixit Mudit, Preparation and Characterization of Spherical agglomerates of Mefenamic acid by neutralization method. IRJP.2010; 1(7): 373-381
  40. Kulkarni P. K., Dixit Mudit, Preparation and Characterization of Spherical agglomerates of Ibuprofen by neutralization method. IRJP.2010; 1(1): 305-313
  41. Morshima K, Kawashima Y, Takuchi H, Niwa T, Hina T. Tabletting Properties of Bucillamine agglomerates prepared by Spherical Crystallization Technique. Int. J. Pharm 105: 11-18 (1994)
  42. Mudit dixit, P.K.Kulkarni, Shanawazanis, Ashwini G kini, Preparation and Characterization of Spherical agglomearets of Ketoprofen by Neutralization method. IJPBS. 2010; 1(4): 394-406s
  43. Nokhodhi A, Maghsood M, Hassangedah D. An improvement of Physicometric properties of Carbamezapine Crystals. Iran. J. Pharm. Res. 6(2) 83-93 (2000)
  44. Patil S. V, PawarAtmaram, SahooSK,Effect of additives on the Physiological and drug release properties of Pioglitazone Hydrochloride Spherical agglomerates. TJPR 2012(2);11 (1): 18- 27
  45. Prabhakar A, Jahhar N, Pawar A. Design and Evaluation of Deformable Talc agglomerates prepared by Crystalo—Co- agglomeration Technique for generating Heterogeneous matrix. AAPS Pharm. Sci. Tech. 8(3): E1-E7 (2007)
  46. Prescott LF, Steel RF, Ferrier WR. The effect of particle size on the absorption of Phenacetin in man. A correlation between plasma concentration of Phenacetin and effects on the central nervous system. ClinPharmacol Ther.1970; 11: 496-504.
  47. Rasmunson CA Katta J. Spherical Crystallization of Benzoic acid. Int. J. Pharm. 348: 61-69 (2008)
  48. Shangraw RF. Compressed tablets by direct compression. In: Lieberman HA, Lachman L, Schwartz JB. Pharmaceutical Dosage Forms: Tablets, vol. 1. Marcel Dekker, New York 1989; pp 195-246
  49. S Kumar, Chawla G, Bansal AK, Spherical Crystallization of Mebendazole to Improve Processibility. PD Techno.2008; 13(6):559-68.
  50. Szabo RP, Goczo H, Pintye H, Kasajr P, Eros I, Hasznos N, Farkas B. Development of spherical crystals of an Aspartic acid salt for direct tablet making. Powder Technology. 2001; 114: 118-24.
  51. Takami K, Machimura H, Takado K, Inagaki M, Kawashima Y. Novel preparation of free flowing spherically agglomerated dibasic calcium phosphate anhydrous for direct tabletting. Chem Pharm Bull. 1996; 44 (4): 686-870.
  52. Usha AN, Mutalik S, Reddy MS, Ranjith AK, Kushtagi P, Udupa N. Prepartion and invitro preclinical and clinical studies of aceclofenac spherical agglomerates. Eur J Pharm Biopharm. 2008; 70: 674-683.
  53. Viswanathan CL, Kulkarni SK, Kolwankar DR. Spherical agglomeration of mefenamic acid and nabumetone to improve micromeritics and solubility: A Technical Note. AAPS Pharm Sci Tech. 2006; 7 (2): Article 48.
  54. Yadav1 VB, Yadav AV. Polymeric Recrystallized agglomerates of Cefuroxime Axetil prepared by Emulsion Solvent Diffusion Technique Trop. J.Pharm. Res. 8(4): 361-369 (2009)
  55. Yadav2VB, Yadav AV. Comparative Tabletting behavior of Carbamezapine granules with Spherical agglomerated Crystals prepared by Spherical Crystallization Technique Int. J. Tech. Res. 1(3): 476-482 (2009).
  56. YadavNamdeo, PawarAtmaram, ParadkarAnant, Effect of Drug Content and agglomerates size on tabletting and drug release characters of Bromhexine HCL-Talc Coagglomerates prepared by CCA. Acta Pharm. 60(2010)25-38.
  57. ZashRanjit, Ajit Kumar, Swain S, Barg M, Choudhary HK, Mehar K, Formulation and Evaluation of Spherical Crystals of Etoricoxib .IJPBA 2011;2(4):1123-1129